In conclusion, our results point to LMP2A-mediated targeting of the EGFR/Ca2+/calpain/ITGβ4 signaling system as a mechanism underlying the increased motility of NPC cells. The gene discussed is ITGB4; the disease is nasopharyngeal carcinoma.